Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis
Bolarinde Ola, Spyros Papaioannou, Masoud A Afnan, Nahed Hammadieh, Silas GimbaVolume:
75
Year:
2001
Language:
english
DOI:
10.1016/s0015-0282(01)01808-8
File:
PDF, 68 KB
english, 2001